Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T16:15:33.690Z.
Calculation as of: 2026-10-06T16:15:33.690Z.
Quote observation: 2026-10-06T16:15:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6ac0f7718e38414e938d0d293bbdd3741326646c7ebae4135e2c8e12d98e3a9c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$984.36M
EV/EBIT Ratio
64.55x
TTM Avg
51.40x
3Y Avg
38.19x
5Y Avg
39.85x
Market Cap
$992.02M
EV/EBIT Ratio
5.22x
TTM Avg
6.47x
3Y Avg
6.47x
5Y Avg
6.47x
Market Cap
$992.10M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$996.94M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$945.88M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.02B
EV/EBIT Ratio
133.32x
TTM Avg
137.89x
3Y Avg
137.89x
5Y Avg
137.89x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aktis Oncology, Inc. (AKTS) | $982.85M | N/A | N/A | N/A | N/A |
| Pacira BioSciences, Inc. (PCRX)vs › | $984.36M | 64.55x | 51.40x | 38.19x | 39.85x |
| MeiraGTx Holdings plc (MGTX)vs › | $992.02M | 5.22x | 6.47x | 6.47x | 6.47x |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $992.10M | N/A | N/A | N/A | N/A |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $996.94M | N/A | N/A | N/A | N/A |
| Kura Oncology, Inc. (KURA)vs › | $954.37M | N/A | N/A | N/A | N/A |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.01B | N/A | N/A | N/A | N/A |
| MoonLake Immunotherapeutics (MLTX)vs › | $945.88M | N/A | N/A | N/A | N/A |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 133.32x | 137.89x | 137.89x | 137.89x |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $935.65M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
